Ind-Swift Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ind-Swift Laboratories Limited with three other
companies in this sector in India:
Astrazeneca Pharma India Ltd
sales of 5.64 billion Indian Rupees [US$87.38 million]
of which 98%
Claris Lifesciences Ltd
(7.54 billion Indian Rupees [US$116.90 million]
Sequent Scientific Limited
(6.34 billion Indian Rupees [US$98.34 million]
of which 99%
Ind-Swift Laboratories Limited reported sales of 6.53 billion Indian Rupees (US$101.25 million)
March of 2016.
decrease of 1.1%
versus 2015, when the company's sales were 6.60 billion Indian Rupees.